BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15509590)

  • 1. PAX4 gene variations predispose to ketosis-prone diabetes.
    Mauvais-Jarvis F; Smith SB; Le May C; Leal SM; Gautier JF; Molokhia M; Riveline JP; Rajan AS; Kevorkian JP; Zhang S; Vexiau P; German MS; Vaisse C
    Hum Mol Genet; 2004 Dec; 13(24):3151-9. PubMed ID: 15509590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome.
    Haaland WC; Scaduto DI; Maldonado MR; Mansouri DL; Nalini R; Iyer D; Patel S; Guthikonda A; Hampe CS; Balasubramanyam A; Metzker ML
    Diabetes Care; 2009 May; 32(5):873-7. PubMed ID: 19228875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
    Biason-Lauber A; Boehm B; Lang-Muritano M; Gauthier BR; Brun T; Wollheim CB; Schoenle EJ
    Diabetologia; 2005 May; 48(5):900-5. PubMed ID: 15834548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes.
    Kooptiwut S; Plengvidhya N; Chukijrungroat T; Sujjitjoon J; Semprasert N; Furuta H; Yenchitsomanus PT
    J Diabetes Complications; 2012; 26(4):343-7. PubMed ID: 22521316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
    Sobngwi E; Gautier JF; Kevorkian JP; Villette JM; Riveline JP; Zhang S; Vexiau P; Leal SM; Vaisse C; Mauvais-Jarvis F
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4446-51. PubMed ID: 15914531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects.
    Sujjitjoon J; Kooptiwut S; Chongjaroen N; Semprasert N; Hanchang W; Chanprasert K; Tangjittipokin W; Yenchitsomanus PT; Plengvidhya N
    J Hum Genet; 2016 Nov; 61(11):943-949. PubMed ID: 27334367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Arg121Trp variant in PAX4 gene is associated with beta-cell dysfunction in Japanese subjects with type 2 diabetes mellitus.
    Tokuyama Y; Matsui K; Ishizuka T; Egashira T; Kanatsuka A
    Metabolism; 2006 Feb; 55(2):213-6. PubMed ID: 16423628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4.
    Kanatsuka A; Tokuyama Y; Nozaki O; Matsui K; Egashira T
    Metabolism; 2002 Sep; 51(9):1161-5. PubMed ID: 12200761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes.
    Louet JF; Smith SB; Gautier JF; Molokhia M; Virally ML; Kevorkian JP; Guillausseau PJ; Vexiau P; Charpentier G; German MS; Vaisse C; Urbanek M; Mauvais-Jarvis F
    Diabetes Obes Metab; 2008 Sep; 10(10):912-20. PubMed ID: 18093211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant mRNA splicing of paired box 4 (PAX4) IVS7-1G>A mutation causing maturity-onset diabetes of the young, type 9.
    Sujjitjoon J; Kooptiwut S; Chongjaroen N; Tangjittipokin W; Plengvidhya N; Yenchitsomanus PT
    Acta Diabetol; 2016 Apr; 53(2):205-16. PubMed ID: 25951767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polymorphism Arg585Gln in the gene of the sterol regulatory element binding protein-1 (SREBP-1) is not a determinant of ketosis prone type 2 diabetes (KPD) in Africans.
    Choukem SP; Boudou P; Sobngwi E; Villette JM; Ibrahim F; Moulin P; Hadjadj S; Eberle D; Foufelle F; Vexiau P; Gautier JF
    Diabetes Metab; 2009 Feb; 35(1):20-4. PubMed ID: 19062325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese.
    Shimajiri Y; Sanke T; Furuta H; Hanabusa T; Nakagawa T; Fujitani Y; Kajimoto Y; Takasu N; Nanjo K
    Diabetes; 2001 Dec; 50(12):2864-9. PubMed ID: 11723072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young.
    Jo W; Endo M; Ishizu K; Nakamura A; Tajima T
    Tohoku J Exp Med; 2011 Feb; 223(2):113-8. PubMed ID: 21263211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter.
    Smith SB; Watada H; Scheel DW; Mrejen C; German MS
    J Biol Chem; 2000 Nov; 275(47):36910-9. PubMed ID: 10967107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission.
    Gosmanov AR; Smiley D; Robalino G; Siqueira JM; Peng L; Kitabchi AE; Umpierrez GE
    Diabetes Care; 2010 Apr; 33(4):854-60. PubMed ID: 20067967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Pax4 paired homeodomain gene by neuron-restrictive silencer factor.
    Kemp DM; Lin JC; Habener JF
    J Biol Chem; 2003 Sep; 278(37):35057-62. PubMed ID: 12829700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX4 mutation (R121W) as a prodiabetic variant in Okinawans.
    Shimajiri Y; Shimabukuro M; Tomoyose T; Yogi H; Komiya I; Takasu N
    Biochem Biophys Res Commun; 2003 Mar; 302(2):342-4. PubMed ID: 12604352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX4 mutations in Thais with maturity onset diabetes of the young.
    Plengvidhya N; Kooptiwut S; Songtawee N; Doi A; Furuta H; Nishi M; Nanjo K; Tantibhedhyangkul W; Boonyasrisawat W; Yenchitsomanus PT; Doria A; Banchuin N
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2821-6. PubMed ID: 17426099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alternative Variants of Pax4 Human Transcription Factor: Comparative Transcriptional Activity].
    Melnikova AI; Krasnova TS; Zubkova NA; Tiulpakov AN; Rubtsov PM
    Mol Biol (Mosk); 2020; 54(5):849-857. PubMed ID: 33009794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes.
    Satomura A; Oikawa Y; Haisa A; Suzuki S; Nakanishi S; Katsuki T; Shimada A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2124-e2132. PubMed ID: 34922394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.